Milwaukee, WI -- Corey Pavin was named this week’s AstraZeneca Charity Challenge winner for his first-place standing entering the final round of the U.S. Bank Championship in Milwaukee. The AstraZeneca Charity Challenge, formerly known as the CRESTOR® Charity Challenge, is a season-long competition that recognizes and rewards the tournament leader entering the final round at 35 PGA TOUR events. Through the sponsorship, AstraZeneca will donate $3.5 million this year to designated health care charities and will have donated a three-year total of $9.7 million by the conclusion of the 2006 PGA TOUR season.

For Pavin’s performance, AstraZeneca will donate $50,000 to the American Heart Association of Wisconsin and $50,000 to the Association of Black Cardiologists (ABC), on behalf of Pavin and the U.S. Bank Championship in Milwaukee.

“AstraZeneca’s generous donation will help the American Heart Association advance groundbreaking medical research, spread lifesaving knowledge and reach out to people of all ages,” said Michel Torbey, M.D., president of the American Heart Association’s Milwaukee Board of Directors. “Projects like the AstraZeneca Charity Challenge demonstrate AstraZeneca’s strong commitment to Milwaukee and communities throughout America.”

“The Association of Black Cardiologists is proud to be recognized as a recipient of the AstraZeneca Charity Challenge,” said Dr. Gerald DeVaughn, President of the Association of Black Cardiologists. “The support of private sector health partners is critical to advancing the health and welfare of our community. We applaud AstraZeneca's vision to reach out and its commitment to partner with us - to assure that African American children grow up knowing the love and nurturing of their grandparents.”

AstraZeneca produces a wide range of products that make significant contributions to treatment options and patient care including CRESTOR, NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year’s sponsorship, as part of its commitment to patient health and well being, AstraZeneca will also designate health care related charities across therapeutic areas as recipients at the 35 PGA TOUR events throughout the year.

“AstraZeneca’s partnership with the PGA TOUR is an integral part of our mission of giving back in local communities throughout America,” said Tony Zook, CEO, AstraZeneca U.S. “The AstraZeneca Charity Challenge offers a unique platform for providing important disease awareness, health information and education to make a difference in the lives of patients and consumers everyday.”

The AstraZeneca Charity Challenge is the centerpiece of a multi-year PGA TOUR partnership with AstraZeneca (NYSE:AZN). Last year, AstraZeneca donated $3.5 million through the program. Highlights from the AZCC include:

•Two weeks ago the AstraZeneca Charity Challenge winner at the John Deere Classic was John Senden. This was Senden’s first AstraZeneca Charity Challenge victory

•At 20 of the 25 tournaments of 2006, the AstraZeneca Charity Challenge winner or co-winner went on to win the tournament

•More than 95 charities have benefited from the program

• Vijay Singh leads all players with nine AstraZeneca Charity Challenge wins. With some of his charitable “winnings,” Singh donated money to the American Red Cross Hurricane Relief Funds in Florida and New Orleans

•Other multiple winners have included Jim Furyk, Tom Lehman, Phil Mickelson and Rod Pampling (four), Stuart Appleby, Chad Campbell, Luke Donald, Sergio Garcia, Carl Petterson, Adam Scott and David Toms (three), and the following players who triumphed twice: Billy Andrade, Bart Bryant, Ben Curtis, Chris DiMarco, Tim Herron, Arron Oberholser, Joe Ogilvie, Kenny Perry, Ted Purdy and Tiger Woods.

Fans can log on to www.astrazeneca.pgatour.com to read about past AstraZeneca Charity Challenge winners and learn more about AstraZeneca.

About American Heart Association Since 1924 the American Heart Association has helped protect people of all ages and ethnicities from the ravages of heart disease and stroke. These diseases, the nation’s No. 1 and No. 3 killers, claim more than 910,000 American lives a year. The association invested more than $429 million in fiscal year 2004–05 for research, professional and public education, advocacy and community service programs so people across America can live stronger, longer lives. For more information, log onto www.americanheart.org.

About Association of Black Cardiologists, Inc. Founded in 1974, the Association of Black Cardiologists, Inc., is a nonprofit organization with an international membership of nearly 600 health care professionals. The ABC is dedicated to eliminating the disparities related to cardiovascular disease in all people. Today, the ABC's public and private partnerships continue to increase its impact in communities across the nation. The ABC’s continuing medical education programs are fully accredited by the Accreditation Council for Continuing Medical Education (ACCME). The ABC is open to all with an interest in cardiovascular disease in underserved communities.

About AstraZeneca AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world’s leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. Worldwide, AstraZeneca has six major research and development sites, four discovery facilities and a clinical research site. In total, AstraZeneca’s R&D organization is comprised of more 11,500 people located in seven countries including Canada, France, India, Japan, Sweden, United Kingdom and the United States.